CSB 4.06(4)(4)Unless otherwise specified by the board, an emergency waiver granted under sub. (3) shall only be effective for 7 days.
CSB 4.06(5)(5)The board may refer a dispenser and dispenser delegate that fail to submit dispensing data or a zero report as required by subs. (1) and (2), or be granted an emergency waiver under sub. (3), or a dispenser and a dispenser delegate that submit false information to the PDMP to the appropriate licensing or regulatory board for discipline.
CSB 4.06 HistoryHistory: CR 12-009: cr. Register October 2012 No. 682, eff. 1-1-13; CR 13-065: am. (1), (2), (3) (intro.), r. (4) to (6), (9), renum. (7) to (4) and am., renum. (8) to (5) Register February 2014 No. 698, eff. 3-1-14; CR 14-003: am. (2), (5) Register August 2014 No. 704, eff. 9-1-14; EmR1706: emerg. am. (1), (2), (3), (5), eff. 4-1-17; CR 17-028: am. (1), (2), (3), (5) Register December 2017 No. 744, eff. 1-1-18.
CSB 4.07CSB 4.07Correction of dispensing data.
CSB 4.07(1)(1) A dispenser shall electronically correct dispensing data in the PDMP system within 5 business days of discovering an omission, error, or inaccuracy in previously submitted dispensing data.
CSB 4.07(2)(2)The board may refer a dispenser and dispenser delegate that fail to correct dispensing data as required by sub. (1) to the appropriate licensing or regulatory board for discipline.
CSB 4.07 NoteNote: The written notice to the board may be submitted through an account with the board, sent by electronic mail or sent by U.S. mail to the Department of Safety and Professional Services 1400 East Washington Avenue, P.O. Box 8366, Madison, WI 53708.
CSB 4.07 HistoryHistory: CR 12-009: cr. Register October 2012 No. 682, eff. 1-1-13; CR 14-003: am. Register August 2014 No. 704, eff. 9-1-14; EmR1706: emerg. r. and recr. eff. 4-1-17; CR 17-028: r. and recr. Register December 2017 No. 744, eff. 1-1-18.
CSB 4.08CSB 4.08Exemptions from compiling and submitting dispensing data.
CSB 4.08(1)(1)The board shall exempt a dispenser from compiling and submitting dispensing data and from submitting a zero report as required under this chapter until the dispenser is required to renew its license, or until the dispenser dispenses a monitored prescription drug, if the dispenser satisfies all of the following conditions:
CSB 4.08(1)(a)(a) The dispenser provides evidence sufficient to the board that the dispenser does not dispense monitored prescription drugs.
CSB 4.08(1)(b)(b) The dispenser files with the board a written request for exemption on a form provided by the board.
CSB 4.08 NoteNote: The application for an exemption may be obtained online at www.dsps.wi.gov or at no charge from the Department of Safety and Professional Services 1400 East Washington Avenue, P.O. Box 8366, Madison, WI 53708. A dispenser who is already exempt can renew his or her exemption as part of the licensure renewal process.
CSB 4.08(2)(2)A dispenser is not required to compile or submit dispensing data when the monitored prescription drug is administered directly to a patient.
CSB 4.08(2m)(2m)A dispenser is not required to compile or submit dispensing data when the monitored prescription drug is compounded, packaged, or labeled in preparation for delivery but is not delivered.
CSB 4.08(3)(3)A dispenser is not required to compile or submit dispensing data when the monitored prescription drug is a substance listed in the schedule in s. 961.22, Stats., and is not a narcotic drug, as defined in s. 961.01 (15), Stats., and is dispensed pursuant to a prescription order for a number of doses that is intended to last the patient 7 days or less.
CSB 4.08(4)(4) A dispenser who is not otherwise required to have a DEA registration number is not required to compile or submit dispensing data when dispensing Gabapentin.
CSB 4.08 HistoryHistory: CR 12-009: cr. Register October 2012 No. 682, eff. 1-1-13; CR 14-003: am. (1) (a), cr. (3) Register August 2014 No. 704, eff. 9-1-14; CR 15-101: am. (1) Register June 2016 No. 726, eff. 7-1-16; EmR1706: emerg. cr. (2m), eff. 4-1-17; CR 17-028: cr. (2m) Register December 2017 No. 744, eff. 1-1-18; CR 20-080: cr. (4) Register August 2021 No. 788, eff. 9-1-21.
CSB 4.09CSB 4.09Access to monitored prescription drug history reports and PDMP data about a patient.
CSB 4.09(1)(1)Healthcare professionals may access monitored prescription drug history reports about a patient for any of the following reasons:
CSB 4.09(1)(a)(a) The healthcare professional is directly treating or rendering assistance to the patient.
CSB 4.09(1)(b)(b) The healthcare professional is being consulted regarding the health of the patient by an individual who is directly treating or rendering assistance to the patient.
CSB 4.09(1)(c)(c) Scientific research purposes if all of the following requirements are met:
CSB 4.09(1)(c)1.1. The patient is a direct patient of the healthcare professional.
CSB 4.09(1)(c)2.2. The healthcare professional has obtained informed consent from the patient to access monitored prescription drug history reports for scientific research purposes.
CSB 4.09(1)(d)(d) Purposes of conducting an overdose fatality review.
CSB 4.09(2)(2)Pharmacist delegates and practitioner delegates may access monitored prescription drug history reports about a patient for any of the following reasons:
CSB 4.09(2)(a)(a) A pharmacist or practitioner who is directly treating or rendering assistance to the patient has delegated the task of obtaining monitored prescription drug history reports about the patient to the pharmacist delegate or practitioner delegate.
CSB 4.09(2)(b)(b) A pharmacist or practitioner who is being consulted regarding the health of the patient by an individual who is directly treating or rendering assistance to the patient has delegated the task of obtaining monitored prescription drug history reports about the patient to the pharmacist delegate or practitioner delegate.